Compare AM & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AM | ALGN |
|---|---|---|
| Founded | 2013 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Industrial Specialties |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 10.5B |
| IPO Year | 2017 | 2000 |
| Metric | AM | ALGN |
|---|---|---|
| Price | $20.88 | $152.97 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 16 |
| Target Price | $24.00 | ★ $188.86 |
| AVG Volume (30 Days) | ★ 2.3M | 830.6K |
| Earning Date | 10-28-2026 | 10-28-2026 |
| Dividend Yield | ★ 4.33% | N/A |
| EPS Growth | ★ 3.61 | 0.53 |
| EPS | 0.48 | ★ 3.09 |
| Revenue | ★ $1,188,426,000.00 | $387,126,000.00 |
| Revenue This Year | $6.47 | $2.80 |
| Revenue Next Year | $9.15 | $3.47 |
| P/E Ratio | ★ $43.31 | $49.32 |
| Revenue Growth | 7.43 | ★ 23.95 |
| 52 Week Low | $16.96 | $130.23 |
| 52 Week High | $23.84 | $200.44 |
| Indicator | AM | ALGN |
|---|---|---|
| Relative Strength Index (RSI) | 48.80 | 55.91 |
| Support Level | $20.75 | $138.05 |
| Resistance Level | $21.70 | $154.10 |
| Average True Range (ATR) | 0.52 | 3.86 |
| MACD | 0.06 | 1.72 |
| Stochastic Oscillator | 70.06 | 80.21 |
Antero Midstream Corp is a midstream company that owns, operates, and develops midstream energy assets that service Antero Resources' production and completion activity in the Appalachian Basin, located in West Virginia and Ohio. The company has two operating segments: the Gathering and Processing segment, which includes a network of gathering pipelines and compressor stations that collect and process production from Antero Resources wells in West Virginia and Ohio, and the Water Handling segment, which includes two independent systems that deliver water from sources including the Ohio River, local reservoirs, and several regional waterways. The company derives a majority of its revenue from the Gathering and Processing segment.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.